Editor profile
Editor, Medical Devices & Hardware
Thomas Müller reports on developments in medical hardware, from robotic surgical systems to high-tech wearables. He tracks the global supply chain of critical diagnostic equipment.
thomas.muller@medtechdaily.orgAccording to the latest report from Healthcare Foresights, the global digital healthcare transformation market will maintain a compound annual growth rate of 14.13% over the next decade. AI, telemedicine, and cloud computing are the main drivers, but cybersecurity and interoperability remain challenges.
From the US FDA to the EU AI Act, major global markets are accelerating the development of regulatory frameworks for AI medical devices. This article reviews regulatory policies, academic research, and industrial impacts from 2015 to 2025.
In 2026, the biotechnology sector is moving from promise to execution. AI-driven R&D, breakthroughs in gene editing, regulatory reforms, and global transactions are reshaping the life sciences landscape. This article examines 26 key trends, covering dimensions such as scientific innovation, emerging markets, policy changes, and business models.
Global digital therapeutics and AI medical device regulation are accelerating, with FDA and NMPA approval numbers hitting record highs and the industry facing new compliance challenges. This article analyzes regulatory strategies, clinical evidence, and market impact.
The global healthcare IT market is growing rapidly. According to the latest industry report, the market size is expected to grow from $246.17 billion in 2024 to $502.91 billion by 2035, with a compound annual growth rate of 6.71%. This article provides an in-depth analysis of key trends such as telemedicine, data interoperability, and cybersecurity, while focusing on regional market landscapes and major company developments, offering forward-looking industry insights for healthcare technology professionals.
AI, predictive modeling, and human-relevant data are transforming drug safety assessment, reducing reliance on animal testing, and improving predictive accuracy. This article analyzes technological advances, industry impacts, and future trends.
The U.S. FDA has announced that Dexcom is the first participant in its TEMPO Digital Health Pilot Program, which allows certain digital health devices to be exempt from premarket review while collecting real-world data through Medicare. Dexcom plans to use AI and continuous glucose monitoring technology to screen for prediabetes and type 2 diabetes, marking a deep integration of regulatory innovation and payment reform.
A joint survey by the American Medical Association (AMA) and Medscape shows that 97% of physicians at least occasionally review patient wearable device data, but fewer than 6% integrate it into clinical workflows. The lack of payment pathways, insufficient electronic health record integration, and concerns about legal liability and reliability are key barriers.
XRHealth acquires digital therapeutics company Swing Therapeutics, integrating the FDA De Novo-authorized Stanza fibromyalgia treatment with its virtual clinic to build a cross-device XR chronic pain management platform, and achieving comprehensive reimbursement through Medicare and commercial insurance.
After withdrawing from the most-favored-nation clause, Danish pharmaceutical procurement agency Amgros has filed a multi-million dollar claim against Amgen. Both parties have hired lawyers, and the case may go to court. This incident reflects the deep contradictions in global drug pricing and healthcare policy.
Discuss the impact of AI on employment in the healthcare industry, analyzing which positions are at risk, which are safe, and the new opportunities created by AI.
Australian Melbourne-based startup Everlab has completed a $46 million Series A funding round, and plans to use its AI-driven preventive healthcare platform to expand into overseas markets such as the UK.
In 2026, Hybrid Care 2.0 integrates AI telemedicine, continuous monitoring, intelligent triage, and predictive analytics into a responsive patient experience, shifting from reactive treatment to proactive prevention. This article analyzes its industry background, key developments, market impact, and future challenges.
Latest industry discussions around Telemedicine, virtual care, and medical collaboration analyze why telemedicine is shifting from a point-of-care consultation tool to cross-institution collaborative infrastructure, and what this means for Digital Health, AI Healthcare, and the restructuring of healthcare institution workflows.